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Abstract The promoter egion of the renin gene in man, mouse 
and rat contains several putative transcription start sites, which 
in mouse have been shown to be tissue specific and differently 
regulated. To investigate which of these start sites are used during 
stimulation of renin gene transcription by the major physiological 
control factors, we determined the trancription start sites of rat 
renin in the kidney and adrenal glands by RNase protection using 
a cRNA probe spanning 387 bases upstream and 121 bases down- 
stream from the canonical transcription initiation site. To stimu- 
late renin gene expression, we used renal artery stenosis, augio- 
tensin II antagonists, furosemide and isoprenaline infusions and 
low sodium diet. Our results suggest hat only one TATA box is 
functional in rat kidney and adrenal. 
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1. Introduction 
The systemic renin angiotensin system (RAS) plays an im- 
portant role in the control of blood pressure and of the extracel- 
lular volume. The activity of the RAS is primarily determined 
by the rate of renin secretion from the kidneys, where renin is 
synthetized, stored and secreted by the juxtaglomerular epithe- 
loid (JGE) cells. A variety of physiological relevant factors 
control concordantly renin secretion and renin gene expression 
in these cells. These factors comprise the intrarenal perfusion 
pressure [l-3], a signal generated by the adjacent tubular mac- 
ula densa cells [4-61, the activity of renal nerves and circulating 
catecholamines [7,8], angiotensin II [9] and salt intake [lO-161. 
With the exception of the renal nerve activity, considered to 
stimulate renin gene expression by increasing CAMP levels in 
the juxtaglomerular cells [ 171, the intracellular pathways medi- 
ating the effects of these rather heterogeneous factors on renin 
gene expression in the JGE cells are largely unknown. Findings 
obtained in vitro suggest that renin gene expression in JG cells 
is stimulated by CAMP and nitric oxide and inhibited by in- 
creased intracellular calcium concentration [18-l 91. Sequence 
analysis of the 5’-flanking region of the renin genes from 
human, mouse and rat revealed the presence of several putative 
promoter regions, so-called TATA boxes [ 17,20-231. The func- 
tionality of these promoters, termed P,,, P, and P2 from 5’ to 
3’ and present in a 150-bp segment preceding exon 1, could in 
part explain the existence of multiple forms of renin in different 
tissues [17,24,25]. Whether factors influencing renin gene ex- 
pression trigger transcription by the use of different start sites 
is at present not understood. In mouse, the preferential use of 
a particular transcription start site appears to be tissue specific 
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and in part influenced by the administration of CAMP [20-221. 
To detect a possible common denominator by which the above- 
mentioned factors could influence renin gene expression, we 
sought to obtain more information about the possible role of 
these additional start sites in the transcription of the renin gene, 
in particular in states of stimulated renin gene expression. 
To localize the transcription start site(s), we constructed a 
cRNA probe covering 387 bases of the promoter and 121 bases 
3’ from the putative transcription start site. With this cRNA, 
we performed RNase protection assay with total RNA isolated 
from the kidneys of the animals subjected to different treatment 
regimen. Stimulation of renin gene expression was achieved by 
renal artery stenosis, by inhibition of the macula densa function 
by the loop diuretic furosemide, by inhibition of angiotensin II 
AT, receptors by losartan, by the /?-adrenergic agonist isopre- 
naline, and by low sodium diet. 
To test for a role of the different putative start sites in the 
organotypic expression of the renin gene, we also used total 
RNA from adrenal glands, because these organs are also con- 
sidered as relevant sites of renin expression. 
Our results show that under all the conditions examined, 
transcription of the renin gene in kidneys and adrenal glands 
started from the same site, which was allocated to the canonical 
TATA box located 27 bp upstream from the transcription start 
site determined by Fukamizu et al. [23]. 
2. Materials and methods 
2.1. Animal experiments 
Male Sprague-Dawley rats (180-220 g) were used for the experi- 
ments: (1) Control rats. (2) Rats with losartan feeding; losartan (40 mg/ 
kg) was administered by gavage in the morning of each experimental 
day for 2 days. (3) Rats with unilateral renal artery clip; rats were 
anesthetized with methohexital (75 mg/kg i.p.) and the left kidney was 
exposed by an abdominal incision. Sterile silver clips (Degussa, Frank- 
furt, Germany) with an id. of 0.2 mm were then placed on the left renal 
arteries. (4) Rats with furosemide infusion; osmotic minipumps (2MLl; 
Alzet, Palo Alto, CA) filled with 100 mg furosemide in 2 ml saline were 
implanted S.C. under the skin of the neck. The daily dosage of furosem- 
ide was 12 mg/animal. To avoid a negative salt and water balance, the 
animals had free access to an additional drinking bottle filled with 0.8% 
NaCl/O. 1% KCI. (5) Rats with isoprenaline infusion; 40 &kg isopre- 
naline were supplied for 36 h with an osmotic minipump. (6) Rats with 
low sodium diet; rats were fed with a low salt diet (Na’ 0.14 mg/g, Cl- 
0.18 mg/g) for 10 days. The salt diet and distilled water were available 
ad libitum. 
2.2. Isolation of RNA 
Total RNA was extracted from the kidneys according to the protocol 
of Chomczynski and Sacchi [26]. Kidneys were homogenized in 10 ml 
of solution D (guanidinium-thiocyanate (4 M) containing 0.5% N- 
lauryl-sarcosinate, 10 mM EDTA, 25 mM sodium citrate and 700 mM 
p-mercaptoethanol) with a polytron homogenizer. Then, 1 ml of 2 M 
sodium acetate, pH 4, and 10 ml ofphenol/chloroform (1: 1) were added 
to the homogenate. Samples were mixed after addition of each reagent. 
After cooling on ice for 15 min, the samples were centrifuged at 
10,000 x g for 15 min at 4°C. RNA was precipitated by adding an equal 
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,,olume of isopropanol at -20°C for at least 1 h. After centrifugation. 
RNA pellets were suspended in 0.5 ml of solution D and again precip- 
tated with an equal volume of isopropanol at -20°C. RNA pellets were 
,inally dissolved in diethypyrocarbonate-treated water and stored at 
-80°C for further processing. 
?.3. RNase protection .for rut preprorenin 
A preprorenin cRNA probe containing 296 bases from exons 1 to I11 
Fig. I), generated from a pSP64 vector carrying a PstI-KpnI restriction 
iagment of a rat preprorenin cDNA was generated by transcription 
,vith SP6 RNA polymerase as described [8]. Transcripts were labelled 
sith [c?P]GTP (410 Ci/mmol). 
cRNA probes (5 x 10” cpm) were hybridized at 60 “C overnight with 
20 pg of total kidney RNA, respectively. with 100 fig total RNA from 
adrenals. RNA was dissolved in 50 ~1 buffer containing 80% forma- 
mide, 40 nmolll l,4-piperazine diethane sulphonic acid (PIPES), 
$00 mmol/l NaCl and I mmol/l EDTA, pH 8. RNase A and Tl diges- 
tion was carried out at 20°C for 30 min and terminated by incubation 
with proteinase K (0.1 mg/ml) and sodium dodecylsulphate (0.4%) at 
37°C for 30 min. Protected mRNA fragments were purified by phenol- 
chloroform extraction. ethanol purification and subsequent electropho- 
resis on a denaturing 10% polyacrylamide gel. After autoradiography 
of the dried gel at -70°C. bands representing the protected renin 
mRNA fragment(s) were excised from the gel and radioactivity was 
counted with a liquid scintillation counter, The number of counts/min 
obtained from each sample of total kidney RNA was expressed relative 
to an external renin mRNA standard included in each hybridization. 
consisting of 20 Bg pooled RNA extracted from the I2 kidneys of six 
normal Sprague- Dawley rats. 
2.4. Determination of renin transcription sturt site(s) 
The existence of multiple transcription start sites for rat renin was 
investigated by RNase protection assay using a 508-base-long cRNA 
probe covering 387 bases of the promoter and 121 bases from the 
putative transcription start site (Fig. 1). The plasmid for the generation 
of the cRNA probe was constructed by PCR-cloning of a fragment of 
the renin gene amplified by the primers Rat ren I (5’CGG GAT CCA 
GAG CAA CAA GAG TGC-3’) and Rat ren 14 (5’-GGA ATT CCA 
AAG CTG GCT GTG TC-3’). Rat ren I and Rat ren 14 hybridize with 
nucleotides 832 to 850, respectively, 132331340 of the rat renin DNA 
sequence [23]. To facilitate cloning, the 5’-end of the primers contained 
BunzHI and EcoRI restriction sites, respectively. After amplification of 
the renin fragment from genomic DNA from the rat liver and BanzHU 
Z?oRI, the fragment was cloned into the respective polylinker site of 
a pGEM 42 vector with was then transformed into E. coli DH5a. 
Sequencing confirmed the identity of the insert with the renin DNA. 
For the generation of cRNA, the plasmid was linearized with HindIII. 
“P-labelled antisense probes were obtained by in vitro transcription 
with SP6 polymerase, according to the protocol of Promega Riboprobe 
System. Transcripts were purified on a Sephadex G50 spun column. 
RNase protection assay was performed as described for preprorenin. 
2.5. Determinution oj‘ociin mRNA 
The abundance of rat cytoplasmatic B-actin in total RNA isolated 
from the kidneys was determined by RNase protection assay exactely 
as described for renin. An actin cRNA probe containing the 76 nucle- 
otide first exon and -200 bases of surrounding sequence was generated 
by transcription with SP6 polymerase from a pAMI vector carrying 
a AvaIIHindlII restriction fragment of actin cDNA. For one assay, 
2.5 pg RNA were hybridized under the conditions described for renin 
mRNA. 
2.6. Determination of plusma renin activity 
Plasma renin activity was determined using a commercial available 
RIA kit for angiotensin I (Sorin Biomedica, Dusseldorf, Germany). 
3. Results 
The existence of different renin transcripts and their eventual 
regulation was investigated in rats with stimulated renin gene 
expression. This was achieved by inducing renal hypoperfusion 
with a 0.2-mm renal artery clip, by inhibiting macula densa 
transport function with the loop diuretic furosemide, by inhib- 
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Fig. I. Schematic presentation of the promoter region of the rat renin 
gene and the construction of the cRNA probes. (a) Structure of the rat 
renin gene (Fukamizu et al. [23]) from exons I to III, with location of 
TATA boxes and transcription start site (v). (b) cRNA probe used in 
RNase protection assays for determination of transcription start sites. 
covering part of the renin promoter comprising the two TATA box and 
part of the first exon. (c) cRNA probe used for renin mRNA measure- 
ments covering part of exons I to III. 
iting angiotensin II AT, receptors with losartan, by p-adrener- 
gic stimulation with isoprenaline and, finally, by keeping the 
animals at low sodium diet for 10 days. 
As shown in Fig. 2 (upper panel), all these maneuvers in- 
creased plasma renin activity. 
Renin mRNA levels in the kidneys of the animals were first 
determined by RNase protection using a cRNA probe protect- 
ing a portion of the renin gene comprised between exons I and 
III (Fig. Ic). The hybridization signals obtained in the assays 
were set in proportion to the signal obtained with an external 
standard run in each experiment and generated by pooling total 
RNA from the kidneys of 6 untreated rats. 
As shown in Fig. 2 (lower panel), renin mRNA levels in- 
creased at all the conditions investigated, with some differences 
in the magnitude of the stimulation. 
Hybridization of 2.5 pug of the RNA samples with a cRNA 
probe for /I-actin showed no significant variations among the 
different experimental conditions (data not shown). 
To localize the transcription start site(s) of the renin gene in 
the animals, total renal RNA was also hybridized with a cRNA 
probe covering 121 bases of the first exon and 387 bases 5’ from 
the putative transcription initiation site (Fig. 1 b). Fig. 3 shows 
a representative autoradiograph of such an assay with total 
renal RNA pooled from the animals of the different treatment 
groups. It is evident that this hybridization always yielded a 
single protected fragment with a size of 121 bp. The intensities 
of the bands corresponded very well with those obtained with 
the probe hybridizing with exons 1 to III. 
Fig. 4 shows a representative autoradiograph of an RNase 
protection assay with the cRNA probe covering the promoter 
region using total RNA from the adrenal glands of animals 
treated with isoprenaline infusions or with low sodium diet. 
Adrenal RNA was pooled from 4 rats for each experimental 
condition. Both isoprenaline infusion and low sodium diet in- 
creased adrenal renin mRNA levels. As for kidney RNA, only 
a single protected fragment with a size of 121 bp was found in 
these organs. 
4. Discussion 
Renin gene expression is physiologically controlled by a 
group of well-characterized but strikingly different factors, 
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,uch as the renal perfusion pressure [l-3], the function of the 
inacula densa [4--61, renal nerve activity [7-S], catecholamines 
1171, angiotensin II [93 and the rate of salt intake [l&14]. With 
I he exception of the renal nerve activity, considered to regulate 
enin gene expression by altering CAMP levels in the juxtaglom- 
rular cells, it is not known how these very heterogeneous 
actors exert their effect at the cellular level, where renin gene 
:xpression has been reported to be stimulated by CAMP and 
iitric oxide levels and inhibited by increased intracellular cal- 
:ium concentration [l&19]. Multiple transcription start sites 
:xist for 5510% of eukaryotic mRNAs [27]: since human, rat 
md mouse renin genes contain several potential transcription 
{tart sites [20-231, it would be conceivable that the different 
‘actors use different promoters and different start sites for renin 
:ene transcription. Indeed, beside the predicted initiator termed 
P,, which is active in the unstimulated state and in the kidney 
Ind in every mouse organ expressing renin mRNA, additional 
transcription start sites were detected in adrenal and testis 
(termed P,,) and submaxillary glands (termed Pi, and P,). S- 
Bromoadenosine 3’,5’-cyclic monophosphate (CAMP) led to 
selective stimulation of P,, in adrenal [21]. This particular tran- 
scription start site (P,,), however. is located within a 476-bp 
insertion of the mouse renin promoter which is absent in man 
and rat [20]. We, therefore, attempted to localize the transcrip- 
tion start sites in conditions in which renin secretion and renin 
gene expression were stimulated. According to previous results, 
we found that renal artery clipping [l-3], inhibition of macula 
densa function [446] or angiotensin AT, receptors [28]. activa- 
tion of /Ladrenergic receptors [7,8] or low sodium diet [lo-141 
caused a substantial activation of renin secretion and renin gene 
expression in the rat. The existence of different renin transcrip- 
tion start sites was analysed by RNase protection assay with 
a cRNA probe covering 121 bases of exon 1 and 387 bases of 
Fig. 2. Plasma renin activity (upper panel) and renin mRNA levels 
(lower panel) in the kidneys of rats treated with renal artery clips, 
losartan, furosemide, low sodium diet or isoprenaline. Renin mRNA 
levels are expressed as percentage of an external standard that was 
generated by pooling renal total RNA from 6 untreated rats. Data are 
mean ? S.E.M. of 5 animals in each group. 
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Fig. 3. Autoradiograph of an RNase protection assay for 20 pg of 
kidney total RNA using the cRNA probe covering the renin promoter/ 
exon I region (Fig. lb). A single protected fragment is visible in animals 
treated with furosemide (lane I ), clipped (lane 2) and contralateral (lane 
3) kidney, losartan (lane 4), low sodium diet (lane 5) isoprenaline (lane 
6) and control (lane 7). Lane 8 corresponds to 20,~g of tRNA. Left are 
0174 DNA/Hid markers. 
the renin promoter from the putative transcription start site 
described by Fukamizu et al. [23]. Within this region, additional 
TATA boxes are located in mouse, man and rat [ 17,20,23]. Only 
a single protected fragment of the apparent size of 121 bp was 
detected, suggesting that at all the conditions relevant for the 
physiological control of renin gene expression a single tran- 
scription start site is utilized in the kidney and that it corre- 
sponds to the one determined in primer extension experiments 
by Fukamizu et al. for rat renin [23]. Our results confirm previ- 
ous findings, suggesting that only a single renin promoter is 
functional in normal mouse kidneys (21,291. Since the use of 
multiple renin transcription start sites has been reported for 
various extrarenal tissues of one-gene and two-gene mouse 
strains [ 17,21,22], we investigated the possible use of additional 
promoters in rat adrenal, where the existence of multiple form 
of renin with an extended NH,-terminus has been reported 
[24,25]. As observed with kidney RNA, in adrenal the same 
single transcription start site was used at all the conditions 
investigated. We could, therefore, not confirm the results ob- 
tained by others. showing the existence of three different renin 
transcripts in mouse adrenal, one (tsp,J being selectively stim- 
ulated by CAMP [21]. Apart from species differences, we have 
no satisfying explanation for these different findings. For these 
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Fig. 4. Autoradiograph of an RNase protection assay for 100 fig adre- 
nal total RNA using the cRNA probe covering the renin promoter/exon 
I region (Fig. lb). A single protected fragment is visible in control 
animals (lane 1) and in animals treated with isoprenaline (lane 2) or low 
sodium diet (lane 3). Lane 4 corresponds to 100 pg of tRNA. Left are 
F174 DNA/%&l markers. 
experiments, we used a RNase protection assay, considered to 
be more sensitive than primer extension technique. Our results 
suggest, therefore, that only a single TATA box is of impor- 
tance for renin expression in the rat. 
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